Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure-Reference-Cited by-同舟云学术

Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure

Published:2017-06-12 Issue:12 Volume:60 Page:5146-5161
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Follmann Markus¹^ORCID,Ackerstaff Jens¹,Redlich Gorden¹,Wunder Frank¹,Lang Dieter¹,Kern Armin¹,Fey Peter¹,Griebenow Nils¹,Kroh Walter¹,Becker-Pelster Eva-Maria¹,Kretschmer Axel¹,Geiss Volker¹,Li Volkhart¹,Straub Alexander¹,Mittendorf Joachim¹,Jautelat Rolf¹,Schirok Hartmut¹,Schlemmer Karl-Heinz¹,Lustig Klemens¹,Gerisch Michael¹,Knorr Andreas¹,Tinel Hanna¹,Mondritzki Thomas¹,Trübel Hubert¹,Sandner Peter¹,Stasch Johannes-Peter¹

Affiliation:

1. Drug Discovery, Bayer AG, Aprather Weg 18a, 42113 Wuppertal, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00449

Reference56 articles.

1. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

2. The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators

3. Cardiovascular cGMP-Generating Systems in Physiological and Pathological Conditions